{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:56:05Z","timestamp":1780736165265,"version":"3.54.1"},"reference-count":22,"publisher":"Georg Thieme Verlag KG","issue":"15","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemolytic disease of the fetus and newborn (HDFN) is associated with significant infant morbidity and mortality. Characteristics of pregnancies impacted by HDFN are not well understood. Therefore, this study examines maternal and infant characteristics based on HDFN status in a large, integrated health care system in the United States.<\/jats:p><jats:p>This was a population-based, retrospective cohort study of 464,711 pregnancies that received care at Kaiser Permanente Southern California (KPSC) hospitals from January 2008 to June 2022. HDFN cases were ascertained using a validated algorithm of structured and unstructured data elements. HDFN due to ABO alloimmunization alone was excluded. Adjusted odds ratios (aORs) derived from logistic regression were used to describe the association between maternal and infant characteristics and HDFN diagnosis as well as adverse perinatal outcomes. For rare events, Firth's bias-reduced logistic regression was applied.<\/jats:p><jats:p>A total of 136 HDFN pregnancies with 138 HDFN births (live births\u2009=\u2009137; stillbirth\u2009=\u20091) were observed in the study. Of three twin pregnancies, all but one fetus had an HDFN diagnosis. HDFN diagnosis was associated with a maternal age of \u226535 years (aOR: 1.74; 95% confidence interval [CI]: 1.13\u20132.67), hypertension (2.07; 0.96\u20134.50), renal disease (3.43; 1.75\u20136.70), and multiparity (4.95; 2.73\u20138.95). Furthermore, HDFN diagnosis was associated with birth at 33 to 34 weeks (aOR: 5.72; 95% CI: 2.78\u201311.78) and 35 to 36 weeks (3.76; 2.38\u20135.94), and neonatal jaundice (3.11; 2.20\u20134.41). Birth weight \u22654,000\u2009g was associated with lower HDFN diagnosis odds than normal weight (2,500\u20133,999\u2009g; aOR: 0.36; 95% CI: 0.14\u20130.90). Hispanic race\/ethnicity was associated with a lower HDFN diagnosis risk than non-Hispanic White (aOR: 0.63; 95% CI: 0.43\u20130.93).<\/jats:p><jats:p>This study identified clinical and demographic factors linked with HDFN diagnosis, including specific maternal characteristics, medical\/obstetrical factors, and neonatal factors, within a large, integrated health care system that can help inform management plans.<\/jats:p>","DOI":"10.1055\/a-2558-7891","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:13:01Z","timestamp":1744917181000},"page":"2038-2048","source":"Crossref","is-referenced-by-count":4,"title":["Hemolytic Disease of the Fetus and Newborn in an Integrated Health Care System"],"prefix":"10.1055","volume":"42","author":[{"given":"Michael J.","family":"Fassett","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, California"},{"name":"Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehaa","family":"Khadka","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-0490","authenticated-orcid":false,"given":"Fagen","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiao","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki Y.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhea","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana A.","family":"Mensah","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Mao","sequence":"additional","affiliation":[{"name":"Janssen Global Services, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Molaei","sequence":"additional","affiliation":[{"name":"Janssen Global Services, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Lin","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-8841","authenticated-orcid":false,"given":"Darios","family":"Getahun","sequence":"additional","affiliation":[{"name":"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California"},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome","volume":"10","author":"C Zwiers","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"M Delaney","year":"2015","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"09","key":"ref3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1701-2163(16)30995-1","article-title":"Prevention of Rh alloimmunization","volume":"25","author":"K Fung Kee Fung","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2146\/ajhp140288","article-title":"Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy","volume":"72","author":"S L Aitken","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40748-021-00129-3","article-title":"Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis","volume":"7","author":"A A Ayenew","year":"2021","journal-title":"Matern Health Neonatol Perinatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/IJWH.S15165","article-title":"Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies","volume":"2","author":"E Osaro","year":"2010","journal-title":"Int J Womens Health"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0973-6247.75963","article-title":"Hemolytic disease of the fetus and newborn: current trends and perspectives","volume":"5","author":"S Basu","year":"2011","journal-title":"Asian J Transfus Sci"},{"issue":"01","key":"ref8","first-page":"11","article-title":"Management of haemolytic disease of the foetus & newborn: steps to improve the outcomes","volume":"138","author":"S E Illanes","year":"2013","journal-title":"Indian J Med Res"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-0528.2009.02244.x","article-title":"Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis","volume":"116","author":"J M Koelewijn","year":"2009","journal-title":"BJOG"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"I MC Ree","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/PHMT.S327032","article-title":"Hemolytic disease of the newborn: a review of current trends and prospects","volume":"12","author":"A K Myle","year":"2021","journal-title":"Pediatric Health Med Ther"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"K J Moise Jr","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajog.2004.06.063","article-title":"Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization","volume":"192","author":"I L Van Kamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"138.e1","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"M S Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"C Koebnick","year":"2012","journal-title":"Perm J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"18-213","DOI":"10.7812\/TPP\/18-213","article-title":"Temporal trends in mortality rates among Kaiser Permanente Southern California Health Plan Enrollees, 2001-2016","volume":"23","author":"W Chen","year":"2019","journal-title":"Perm J"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12872-021-02075-6","article-title":"Temporal trends in heart failure mortality in an integrated healthcare delivery system, California, and the US, 2001-2017","volume":"21","author":"M T Mefford","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/a-2444-2314","article-title":"Identifying hemolytic disease of the fetus and newborn within a large integrated health care system","author":"F Xie","year":"2024","journal-title":"Am J Perinatol"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.semperi.2011.02.009","article-title":"Diagnostic laboratory technologies for the fetus and neonate with isoimmunization","volume":"35","author":"S M Geaghan","year":"2011","journal-title":"Semin Perinatol"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"D Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2011.09.024","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study","volume":"206","author":"I T Lindenburg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17474086.2022.2138853","article-title":"Identification and management of fetal anemia due to hemolytic disease","volume":"15","author":"R M van 't Oever","year":"2022","journal-title":"Expert Rev Hematol"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2558-7891.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:45:24Z","timestamp":1760654724000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2558-7891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":22,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,10,16]]},"published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2558-7891","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}